CMS Innovation Council To Examine Pharmacogenomic Product Coverage
Executive Summary
The Centers for Medicare & Medicaid Services' Council for Technology & Innovation will consider coverage of pharmacogenomic products
You may also be interested in...
CMS Developing Guidance On Coverage Decisions For Clinical Trials
The Centers for Medicare & Medicaid Services will produce a guidance document on Medicare coverage of products used in clinical trials or registries
CMS Developing Guidance On Coverage Decisions For Clinical Trials
The Centers for Medicare & Medicaid Services will produce a guidance document on Medicare coverage of products used in clinical trials or registries
Medicare Drug Coding Drops Six-Month Marketing Requirement
Pharmaceutical manufacturers will no longer need to submit six months of marketing data for a drug when seeking a Medicare reimbursement code